Have been treated with felbamate or vigabatrin within the 6 months prior to Screening If a subject has been previously treated with vigabatrin 6 months prior to Screening a visual perimetry test performed within 6 months prior to Screening must show normal visual fields or no worsening of recognised visual field abnormalities as compared with prior to vigabatrin treatment 